• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lumos Pharma Inc (NQ: LUMO )

    4.415 UNCHANGED
    Streaming Delayed Price Updated: 3:57 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Lumos Pharma Inc

    < Previous 1 2 Next >
    Analyst Expectations For Lumos Pharma's Future
    Via Benzinga
    LUMO Stock Earnings: Lumos Pharma Misses EPS, Misses Revenue for Q1 2024
    LUMO stock results show that Lumos Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    LUMO Stock Earnings: Lumos Pharma Misses EPS for Q4 2023
    LUMO stock results show that Lumos Pharma missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Lumos Pharma: Q4 Earnings Insights
    Via Benzinga
    Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today?
    Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 Pharmacokinetic/Pharmacodynamic (PK/PD) trial met all... 
    Via Benzinga
    Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What 7 Analyst Ratings Have To Say About Lumos Pharma
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
    Via Benzinga
    Earnings Preview: Lumos Pharma
    Via Benzinga
    Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    The Latest Analyst Ratings for Lumos Pharma
    Via Benzinga
    Lumos Pharma: Q1 Earnings Insights
    Via Benzinga
    Earnings Scheduled For March 1, 2023
    Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
    Via Benzinga
    A Preview Of Lumos Pharma's Earnings
    Via Benzinga
    Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
    Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Lumos Pharma Earnings Perspective: Return On Capital Employed
    Via Benzinga
    Lumos Pharma Says Growth Hormone Deficiency Trial Meet Expectations
    Via Benzinga
    Recap: Lumos Pharma Q2 Earnings
      Lumos Pharma (NASDAQ:LUMO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 34 companies set new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 64 companies achieved new lows for the year. 
    Via Benzinga
    Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
    U.S. stocks traded mixed, with the Nasdaq gaining more than 50 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
    Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
    Via Benzinga
    Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
    Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
    Via Benzinga
    Earnings Outlook For Lumos Pharma
      Lumos Pharma (NASDAQ:LUMO) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Lumos Pharma... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.